<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

News and Stories


Neuroscience    Pharmaceutical Sciences    Alzheimer's   

Researchers Describe Tools to Better Understand CaMKII, a Protein Involved in Brain and Heart Disease

The health impacts of a complex protein that plays a major role in the development of Alzheimer’s disease and heart conditions can be lessened by three kinds of drug inhibitors, according to scientists at the University of Colorado Anschutz Medical Campus.

Author David Kelly | Publish Date March 22, 2024
Full Story

Neuroscience    Alzheimer's    Clinic-Based Pharmacy

Blocking Key Protein May Halt Alzheimer’s Progression

Researchers at the University of Colorado Anschutz Medical Campus have found that inhibiting a key protein can stop the destruction of synapses and dendritic spines commonly seen in Alzheimer’s disease.

Author David Kelly | Publish Date February 20, 2024
Full Story

Research    Alzheimer's   

Alzheimer’s Study Finds Potential Immune System Link, Mostly in Women

When immune systems go awry, they can wreak havoc, triggering everything from diabetes to – scientists now believe – Alzheimer’s disease (AD). But immune systems are supposed to protect, not injure, the body. So what if scientists could pinpoint a window before things go amiss and harness the defense system in a way that curbs or prevents AD from taking hold?

Author Debra Melani | Publish Date February 05, 2024
Full Story

Neuroscience    Pharmaceutical Sciences    Alzheimer's   

Discoveries on Memory Mechanisms Could Unlock New Therapies for Alzheimer’s and other Brain Diseases

Scientists at the University of Colorado Anschutz Medical Campus have made a `paradigm shifting’ discovery on the mechanisms required for learning and memory that could lead to new therapies for Alzheimer’s disease and potentially Down syndrome.

Author David Kelly | Publish Date August 30, 2023
Full Story

Press Releases    Alzheimer's   

'A Fitness Tracker for Brain Health': Headband Seeks Early Signs of Alzheimer’s During Sleep

Researchers from the University of Colorado Anschutz Medical Campus and Washington University in St. Louis have identified a way to assess brain activity in sleep that occurs in the earliest stages of Alzheimer’s disease, typically many years prior to developing symptoms of dementia.

Author Kelsea Pieters | Publish Date August 23, 2023
Full Story

Research    Patient Care    Advancement    Alzheimer's   

Q&A: Experts Weigh in on Alzheimer’s Disease and Discovery

As the number of Americans living with Alzheimer’s disease is expected to triple by 2050, the sense of urgency for researchers to find better treatments and, ultimately, a cure for the 6 million people whose memories and lives are at stake has intensified.

Author Guest Contributor | Publish Date May 31, 2023
Full Story

Diabetes    Geriatrics    Alzheimer's   

Study Suggests Fructose Could Drive Alzheimer's Disease

An ancient human foraging instinct, fueled by fructose production in the brain, may hold clues to the development and possible treatment of Alzheimer’s disease (AD), according to researchers at the University of Colorado Anschutz Medical Campus.

Author David Kelly | Publish Date February 13, 2023
Full Story

Neuroscience    Alzheimer's    Infectious disease

Olfactory Viral Inflammation Associated with Accelerated Onset of Alzheimer’s disease

Viruses can inflame and disrupt connections between the olfactory system, which governs the sense of smell, and the part of the brain associated with memory and learning, possibly accelerating the onset of Alzheimer’s disease, according to a new study from researchers at the University of Colorado Anschutz Medical Campus.

Author David Kelly | Publish Date December 14, 2022
Full Story

Research    Alzheimer's

Chris Hemsworth Learns of Heightened Alzheimer’s Risk

Superman had kryptonite. Thor has two copies of the gene ApoE4.

One is a fictional material. The other is a real-life genetic characteristic that signals a greater likelihood of developing Alzheimer’s disease.

Chris Hemsworth, who plays the Norse warrior armed with a trademark hammer, recently learned he has copies of the gene, one from his mother and one from his father. The genetic rarity – carried by only 2% to 3% of the population – makes Hemsworth eight to 10 times more likely to develop Alzheimer’s.

Author Staff | Publish Date November 22, 2022
Full Story

Neuroscience    Geriatrics    Alzheimer's

Gene Involved in Neuronal Structure and Function May Protect Against Alzheimer’s Disease

The overexpression of a gene tied to cell division and the structure and function of neurons may prevent and protect against cognitive decline in both mice and humans with Alzheimer’s disease (AD), according to a new study by scientists at the University of Colorado Anschutz Medical Campus.

Author David Kelly | Publish Date October 25, 2022
Full Story

Research    Press Releases    Neuroscience    Clinical Research    Clinical    Alzheimer's

Study Provides Insight into Vagus Nerve’s Link to Brain

Researchers at the University of Colorado Anschutz Medical Campus have shown a direct link between vagus nerve stimulation and its connection to the learning centers of the brain. The discovery may lead to treatments that will improve cognitive retention in both healthy and injured nervous systems.

Author Laura Kelley | Publish Date July 28, 2022
Full Story

Research    Patient Care    CU Anschutz 360 Podcast    Alzheimer's

Could Viruses, Olfactory ‘Railroad Track’ Unlock Alzheimer’s Puzzle?

More than one in nine Americans 65 and older are now battling Alzheimer’s disease, and the numbers are expected to greatly increase in the coming decades as our population ages.

Author Chris Casey | Publish Date March 11, 2022
Full Story